185 related articles for article (PubMed ID: 22938900)
21. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
Yadav S; Sharma P; Zakalik D
Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
[TBL] [Abstract][Full Text] [Related]
22. Five-Year Actual Overall Survival in Resected Pancreatic Cancer: A Contemporary Single-Institution Experience from a Multidisciplinary Perspective.
Picozzi VJ; Oh SY; Edwards A; Mandelson MT; Dorer R; Rocha FG; Alseidi A; Biehl T; Traverso LW; Helton WS; Kozarek RA
Ann Surg Oncol; 2017 Jun; 24(6):1722-1730. PubMed ID: 28054192
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Treatment Patterns and Survival Outcomes in Elderly Pancreatic Cancer Patients: A Surveillance, Epidemiology, and End Results-Medicare Analysis.
Shaib WL; Jones JS; Goodman M; Sarmiento JM; Maithel SK; Cardona K; Kane S; Wu C; Alese OB; El-Rayes BF
Oncologist; 2018 Jun; 23(6):704-711. PubMed ID: 29445028
[TBL] [Abstract][Full Text] [Related]
24. Time to the initiation of adjuvant chemotherapy does not impact survival in patients with resected pancreatic cancer.
Mirkin KA; Greenleaf EK; Hollenbeak CS; Wong J
Cancer; 2016 Oct; 122(19):2979-87. PubMed ID: 27328270
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
Abdel-Rahman O
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
[TBL] [Abstract][Full Text] [Related]
26. Benefit of postoperative adjuvant therapy for pancreatic cancer: A population-based analysis.
Vanderveen KA; Chen SL; Yin D; Cress RD; Bold RJ
Cancer; 2009 Jun; 115(11):2420-9. PubMed ID: 19301434
[TBL] [Abstract][Full Text] [Related]
27. Association of Timing of Adjuvant Therapy With Survival in Patients With Resected Stage I to II Pancreatic Cancer.
Ma SJ; Oladeru OT; Miccio JA; Iovoli AJ; Hermann GM; Singh AK
JAMA Netw Open; 2019 Aug; 2(8):e199126. PubMed ID: 31411712
[TBL] [Abstract][Full Text] [Related]
28. Regional variation in the treatment of pancreatic adenocarcinoma: Decreasing disparities with multimodality therapy.
Kasumova GG; Eskander MF; de Geus SWL; Neto MM; Tabatabaie O; Ng SC; Miksad RA; Mahadevan A; Rodrigue JR; Tseng JF
Surgery; 2017 Aug; 162(2):275-284. PubMed ID: 28487044
[TBL] [Abstract][Full Text] [Related]
29. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.
Labori KJ; Katz MH; Tzeng CW; Bjørnbeth BA; Cvancarova M; Edwin B; Kure EH; Eide TJ; Dueland S; Buanes T; Gladhaug IP
Acta Oncol; 2016; 55(3):265-77. PubMed ID: 26213211
[TBL] [Abstract][Full Text] [Related]
30. Association of time-to-surgery with outcomes in clinical stage I-II pancreatic adenocarcinoma treated with upfront surgery.
Swords DS; Zhang C; Presson AP; Firpo MA; Mulvihill SJ; Scaife CL
Surgery; 2018 Apr; 163(4):753-760. PubMed ID: 29248179
[TBL] [Abstract][Full Text] [Related]
31. Accuracy of staging node-negative pancreas cancer: a potential quality measure.
Tomlinson JS; Jain S; Bentrem DJ; Sekeris EG; Maggard MA; Hines OJ; Reber HA; Ko CY
Arch Surg; 2007 Aug; 142(8):767-723; discussion 773-4. PubMed ID: 17709731
[TBL] [Abstract][Full Text] [Related]
32. Redefining the Positive Margin in Pancreatic Cancer: Impact on Patterns of Failure, Long-Term Survival and Adjuvant Therapy.
Osipov A; Nissen N; Rutgers J; Dhall D; Naziri J; Chopra S; Li Q; Hendifar AE; Tuli R
Ann Surg Oncol; 2017 Nov; 24(12):3674-3682. PubMed ID: 28871564
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
Stessin AM; Meyer JE; Sherr DL
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1128-33. PubMed ID: 18538501
[TBL] [Abstract][Full Text] [Related]
34. Implications of inaccurate clinical nodal staging in pancreatic adenocarcinoma.
Swords DS; Firpo MA; Johnson KM; Boucher KM; Scaife CL; Mulvihill SJ
Surgery; 2017 Jul; 162(1):104-111. PubMed ID: 28238344
[TBL] [Abstract][Full Text] [Related]
35. Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head.
Lutfi W; Talamonti MS; Kantor O; Wang CH; Liederbach E; Stocker SJ; Bentrem DJ; Roggin KK; Winchester DJ; Marsh R; Prinz RA; Baker MS
Surgery; 2016 Sep; 160(3):714-24. PubMed ID: 27422328
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors associated with long-term survival and recurrence in pancreatic adenocarcinoma.
Lee SR; Kim HO; Son BH; Yoo CH; Shin JH
Hepatogastroenterology; 2013; 60(122):358-62. PubMed ID: 23574658
[TBL] [Abstract][Full Text] [Related]
37. Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base.
Rutter CE; Park HS; Corso CD; Lester-Coll NH; Mancini BR; Yeboa DN; Johung KL
Cancer; 2015 Dec; 121(23):4141-9. PubMed ID: 26280559
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the prognostic value of the new AJCC 8th edition staging system for patients with pancreatic adenocarcinoma; a need to subclassify stage III?
Song M; Yoon SB; Lee IS; Hong TH; Choi HJ; Choi MH; Lee MA; Jung ES; Choi MG
Eur J Cancer; 2018 Nov; 104():62-69. PubMed ID: 30326370
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of venous invasion in resected T3 pancreatic adenocarcinoma: Depth of invasion matters.
Addeo P; Velten M; Averous G; Faitot F; Nguimpi-Tambou M; Nappo G; Felli E; Fuchshuber P; Bachellier P
Surgery; 2017 Aug; 162(2):264-274. PubMed ID: 28576385
[TBL] [Abstract][Full Text] [Related]
40. Significance of pathologic response to preoperative therapy in pancreatic cancer.
Chun YS; Cooper HS; Cohen SJ; Konski A; Burtness B; Denlinger CS; Astsaturov I; Hall MJ; Hoffman JP
Ann Surg Oncol; 2011 Dec; 18(13):3601-7. PubMed ID: 21947697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
